Drug Abuse Testing Market

Drug of Abuse Testing Market Information, by Test type (Onsite Screening Test, Laboratory Drug Testing), by Sample (Urine, Hair, Saliva) - Forecast to 2020

Market Synopsis of Drug of Abuse Testing Market:

Market Scenario:

Drug of abuse testing is based on diagnosing drug addiction, also called substance use disorder, requiring a thorough evaluation and often includes an assessment by a psychiatrist, a psychologist, or a licensed alcohol and drug counselor. Blood, urine or other lab tests are used to assess drug use, but they're not a diagnostic test for addiction. These tests may be used for monitoring treatment. The factor which may influence the growth of the drug of abuse testing market is increased use of drug testing at organizational level, increased production and trade of illicit drugs worldwide and others. Globally the market for drug of abuse testing is expected to grow at 5.3% GAGR from 2016 to 2020.

Drug of Abuse Testing Market, by Sample (%)

Intended Audience

• Drug of abuse testing companies


• Drug of abuse testing reagent Manufacturers


• Hospitals and Clinics


• Diagnostics Centers


• National Organizations & Government Organizations


• Academic research institutes


• Government institutes

Key Players for Drug of Abuse Testing Market:                                            

Some of the key players in this market are: Roche Holding Limited, Quest Diagnostics, Laboratory Corporation of America Holdings, Alere Inc, Abbott Laboratories, Randox Laboratories Ltd, Psychemedics Corporation, Bio-Rad Laboratories, Inc, Sonic Healthcare and Thermo Fisher Scientific Inc.

Study Objectives of the Market:

• To provide detailed analysis of the market structure along with forecast for the next 9 years of the various segments and sub-segments of the drug of abuse testing market


• To provide insights about factors affecting the market growth


• To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.


• To provide forecast revenue of the market segments and sub-segments with respect to the main geography and various regions globally.


• To provide regional level analysis of the market with respect to the current market size and future prospective


• To provide regional level analysis of the market for segments by test type, by sample and its sub-segments.


• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market


• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global drug of abuse testing market.

Key Finding

• The global drug of abuse testing market is expected to reach $3.0 billion in 2020, mainly driven by increased use of illicit drugs and need of drug abuse testing at organizational level.


• Onsite testing market is more than double the size of laboratory testing due to ease of use, cost effectiveness and immediate results.


• Urine followed by saliva is the most common specimen used in the drug of abuse testing. Hair as a specimen is also becoming a more effective way for testing long term drug use.


• North America was the largest market by geography for drug abuse testing in 2014, with 76.4% share of the total market

Segments:

Global drug of abuse testing market is mainly segmented into test type and samples. Furthermore the test type is segmented into onsite screening test and laboratory drug testing. On the bases of samples the market is segmented into urine, hair, saliva and others.   

Regional Analysis of Drug of Abuse Testing Market:                                             

Globally Americas is the largest market for drug of abuse testing market. Europe is the second-largest for drug of abuse testing market. Europe drug of abuse testing market is expected to grow with a steady pace.